University of California San Francisco
Working in mice, UCSF researchers have found that a recently discovered subset of cells in the immune system may prevent the mother’s immune system from attacking the placenta and fetus.
Messenger RNA vaccines against COVID-19 were not detected in human milk, according to a small study by UCSF, providing early evidence that the vaccine mRNA is not transferred to the infant.
A UCSF study has found that the antibiotic azithromycin was no more effective than a placebo in preventing symptoms of COVID-19 among non-hospitalized patients, and may increase their chance of hospitalization, despite widespread prescription of the antibiotic for the disease.
In a promising pairing of science and art, UC San Francisco – one of the world’s premier health science universities – has hired two renowned firms, HGA and Snøhetta, to design a new Research and Academic Building on UCSF’s Parnassus Heights Campus.
Researchers at UC San Francisco have successfully developed a “speech neuroprosthesis” that has enabled a man with severe paralysis to communicate in sentences, translating signals from his brain to the vocal tract directly into words that appear as text on a screen.
A study by UCSF researchers found that about one in four unvaccinated people aged 18 to 25 said that they “probably will not” or “definitely will not” get the COVID-19 vaccination.
UCSF, Johns Hopkins Medicine, and collaborators across the country have created a national guideline on educational priorities on firearm injury prevention for health professionals.
Children with a devastating genetic disorder characterized by severe motor disability and developmental delay have experienced sometimes dramatic improvements in a gene therapy trial launched at UCSF Benioff Children’s Hospitals.
Scientists at UCSF have shown that gene-edited cellular therapeutics can be used to successfully treat cardiovascular and pulmonary diseases in mice.
Taking a page from computer engineers, biologists are trying their hands at programming cells – by building DNA circuits to guide their protein-making machinery and behavior.
UCSF Benioff Children’s Hospitals is poised to lead the UC System and the state in pediatric medicine, according to its two senior leaders, who held a virtual fireside chat to discuss the past,
Plenty of probiotic yogurts, pickles and kombuchas claim to boost our digestive health with armies of microbes, but some scientists have more ambitious therapeutic plans for the “bugs” that colonize us. They hope to leverage these microbes as living therapeutics for a range of health conditions, including ulcerative colitis, multiple sclerosis, eczema and asthma.
Pioneer, giant, visionary – these are just a few of the words that describe John Severinghaus and his work to advance anesthesia and medicine.
Every year, 10,000 liters of liquid helium are used by just two imaging facilities housed at UCSF’s Mission Bay campus managed by the UCSF Schools of Pharmacy and Medicine—enough to fill 625,000 birthday balloons.
Researchers at UC San Francisco have found that extreme caloric restriction diets alter the microbiome in ways that could help with weight loss but might also result in an increased population of Clostridioides difficile, a pathogenic bacterium that can lead to severe diarrhea and colitis.
At the recent June Precision Medicine World Conference, scientists and health experts from academia, government, and industry discussed how a precision medicine approached has helped to curb the pandemic and how lessons learned can be used to build resilience against future threats.
There is a chance that in every lecture, laboratory, Zoom meeting, town hall audience or shuttle bus ride, someone around you is battling a mental health challenge or knows someone who is struggling.
Individuals with HIV are more than twice as likely to die from sudden cardiac death (SCD) compared to the general population, and more likely to have hearts compromised by fibrosis, a factor that may play a role in increasing their susceptibility to SCD, according to new findings from a UCSF study.
This long-delayed treatment milestone might not have happened at all without seminal accomplishments by UCSF chemist Kevan Shokat, who succeeded in revitalizing a holy-grail-like quest after almost all others had given up.
T cells – immune cells that patrol our bodies in search of trouble – have become a central focus for UC San Francisco scientists working on living cell therapies, an approach that views cells
